Literature DB >> 12015999

Proteomic map and database of lymphoblastoid proteins.

Michel Caron1, Naima Imam-Sghiouar, Florence Poirier, Jean-Pierre Le Caër, Valerie Labas, Raymonde Joubert-Caron.   

Abstract

Advances in genomics have led to the accumulation of an unprecedented amount of data, giving rise to a new field in biochemistry, proteomics. We used a combination of two dimensional gel electrophoresis, analysis and annotation using third-generation software, and mass spectrometry to establish the proteome maps of lymphoblastoid B-cells, a prerequisite for analysis of drug effects and lymphocyte cell diseases. About 1200 protein spots were detected and characterised in terms of their isoelectric point, molecular mass and expression. The present status of proteomic technologies, as well as a description of the usefulness of human hematopoietic cells proteomic database are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015999     DOI: 10.1016/s1570-0232(02)00040-5

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

Review 1.  Contributions to our understanding of T cell physiology through unveiling the T cell proteome.

Authors:  M M Grant; D Scheel-Toellner; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

2.  Robust imaging and gene delivery to study human lymphoblastoid cell lines.

Authors:  Lachlan A Jolly; Ying Sun; Renée Carroll; Claire C Homan; Jozef Gecz
Journal:  J Hum Genet       Date:  2018-06-20       Impact factor: 3.172

3.  Molecular weight assessment of proteins in total proteome profiles using 1D-PAGE and LC/MS/MS.

Authors:  Q Rushdy Ahmad; Dat H Nguyen; Mark A Wingerd; George M Church; Martin A Steffen
Journal:  Proteome Sci       Date:  2005-06-08       Impact factor: 2.480

4.  Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.

Authors:  Serena Giuliano; Anna Maria Agresta; Antonella De Palma; Simona Viglio; Pierluigi Mauri; Marco Fumagalli; Paolo Iadarola; Lorenza Montalbetti; Roberta Salvini; Anna Bardoni
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

5.  Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.

Authors:  Rui Wu; Marcel Nijland; Bea Rutgers; Rianne Veenstra; Myra Langendonk; Lotte E van der Meeren; Philip M Kluin; Guanwu Li; Arjan Diepstra; Jen-Fu Chiu; Anke van den Berg; Lydia Visser
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

6.  Mercury immune toxicity in harbour seals: links to in vitro toxicity.

Authors:  Krishna Das; Ursula Siebert; Audrey Gillet; Aurélie Dupont; Carole Di-Poï; Sonja Fonfara; Gabriel Mazzucchelli; Edwin De Pauw; Marie-Claire De Pauw-Gillet
Journal:  Environ Health       Date:  2008-10-29       Impact factor: 5.984

7.  Proteomic analysis of the differential protein expression reveals nuclear GAPDH in activated T lymphocytes.

Authors:  Wei-Yun Sheng; Tzu-Chien V Wang
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

Review 8.  Lymphoblastoid Cell lines: a Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair.

Authors:  Tabish Hussain; Rita Mulherkar
Journal:  Int J Mol Cell Med       Date:  2012

9.  In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sjögren syndrome.

Authors:  Laxmikanth Kollipara; Stephan Buchkremer; José Andrés González Coraspe; Denisa Hathazi; Jan Senderek; Joachim Weis; René P Zahedi; Andreas Roos
Journal:  Oncotarget       Date:  2017-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.